Click for best price
Coagulation Factor XI Market Size, Share 2022
This report contains market size and forecasts of Coagulation Factor XI in Global, including the following market information:
Global Coagulation Factor XI Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Coagulation Factor XI market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
MR-1007 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Coagulation Factor XI include Bayer AG, Bristol-Myers Squibb Company, Cambryn Biologics LLC, eXithera Pharmaceuticals, Inc, Ionis Pharmaceuticals, Inc. and LegoChem Biosciences, Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Coagulation Factor XI companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Coagulation Factor XI Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Coagulation Factor XI Market Segment Percentages, by Type, 2021 (%)
MR-1007
IONIS-FXIRx
EP-7041
AB-022
BMS-262084
Others
Global Coagulation Factor XI Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Coagulation Factor XI Market Segment Percentages, by Application, 2021 (%)
Thrombosis
Bleeding and Clotting Disorders
Acute Ischemic Stroke
Others
Global Coagulation Factor XI Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Coagulation Factor XI Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Coagulation Factor XI revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Coagulation Factor XI revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics LLC
eXithera Pharmaceuticals, Inc
Ionis Pharmaceuticals, Inc.
LegoChem Biosciences, Inc
Report Attributes |
Report Details |
Report Title |
Coagulation Factor XI Market, Global Outlook and Forecast 2022-2028 |
Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
Base Year |
2021 |
Forecast Year |
2029 |
Number of Pages |
64 Pages |
Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Coagulation Factor XI Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Coagulation Factor XI Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Coagulation Factor XI Overall Market Size
2.1 Global Coagulation Factor XI Market Size: 2021 VS 2028
2.2 Global Coagulation Factor XI Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Coagulation Factor XI Players in Global Market
3.2 Top Global Coagulation Factor XI Companies Ranked by Revenue
3.3 Global Coagulation Factor XI Revenue by Companies
3.4 Top 3 and Top 5 Coagulation Factor XI Companies in Global Market, by Revenue in 2021
3.5 Global Companies Coagulation Factor XI Product Type
3.6 Tier 1, Tier 2 and Tier 3 Coagulation Factor XI Players in Global Market
3.6.1 List of Global Tier 1 Coagulation Factor XI Companies
3.6.2 List of Global Tier 2 and Tier 3 Coagulation Factor XI Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Coagulation Factor XI Market Size Markets, 2021 & 2028
4.1.2 MR-1007
4.1.3 IONIS-FXIRx
4.1.4 EP-7041
4.1.5 AB-022
4.1.6 BMS-262084
4.1.7 Others
4.2 By Type - Global Coagulation Factor XI Revenue & Forecasts
4.2.1 By Type - Global Coagulation Factor XI Revenue, 2017-2022
4.2.2 By Type - Global Coagulation Factor XI Revenue, 2023-2028
4.2.3 By Type - Global Coagulation Factor XI Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Coagulation Factor XI Market Size, 2021 & 2028
5.1.2 Thrombosis
5.1.3 Bleeding and Clotting Disorders
5.1.4 Acute Ischemic Stroke
5.1.5 Others
5.2 By Application - Global Coagulation Factor XI Revenue & Forecasts
5.2.1 By Application - Global Coagulation Factor XI Revenue, 2017-2022
5.2.2 By Application - Global Coagulation Factor XI Revenue, 2023-2028
5.2.3 By Application - Global Coagulation Factor XI Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Coagulation Factor XI Market Size, 2021 & 2028
6.2 By Region - Global Coagulation Factor XI Revenue & Forecasts
6.2.1 By Region - Global Coagulation Factor XI Revenue, 2017-2022
6.2.2 By Region - Global Coagulation Factor XI Revenue, 2023-2028
6.2.3 By Region - Global Coagulation Factor XI Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Coagulation Factor XI Revenue, 2017-2028
6.3.2 US Coagulation Factor XI Market Size, 2017-2028
6.3.3 Canada Coagulation Factor XI Market Size, 2017-2028
6.3.4 Mexico Coagulation Factor XI Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Coagulation Factor XI Revenue, 2017-2028
6.4.2 Germany Coagulation Factor XI Market Size, 2017-2028
6.4.3 France Coagulation Factor XI Market Size, 2017-2028
6.4.4 U.K. Coagulation Factor XI Market Size, 2017-2028
6.4.5 Italy Coagulation Factor XI Market Size, 2017-2028
6.4.6 Russia Coagulation Factor XI Market Size, 2017-2028
6.4.7 Nordic Countries Coagulation Factor XI Market Size, 2017-2028
6.4.8 Benelux Coagulation Factor XI Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Coagulation Factor XI Revenue, 2017-2028
6.5.2 China Coagulation Factor XI Market Size, 2017-2028
6.5.3 Japan Coagulation Factor XI Market Size, 2017-2028
6.5.4 South Korea Coagulation Factor XI Market Size, 2017-2028
6.5.5 Southeast Asia Coagulation Factor XI Market Size, 2017-2028
6.5.6 India Coagulation Factor XI Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Coagulation Factor XI Revenue, 2017-2028
6.6.2 Brazil Coagulation Factor XI Market Size, 2017-2028
6.6.3 Argentina Coagulation Factor XI Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Coagulation Factor XI Revenue, 2017-2028
6.7.2 Turkey Coagulation Factor XI Market Size, 2017-2028
6.7.3 Israel Coagulation Factor XI Market Size, 2017-2028
6.7.4 Saudi Arabia Coagulation Factor XI Market Size, 2017-2028
6.7.5 UAE Coagulation Factor XI Market Size, 2017-2028
7 Players Profiles
7.1 Bayer AG
7.1.1 Bayer AG Corporate Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Coagulation Factor XI Major Product Offerings
7.1.4 Bayer AG Coagulation Factor XI Revenue in Global Market (2017-2022)
7.1.5 Bayer AG Key News
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporate Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Coagulation Factor XI Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Coagulation Factor XI Revenue in Global Market (2017-2022)
7.2.5 Bristol-Myers Squibb Company Key News
7.3 Cambryn Biologics LLC
7.3.1 Cambryn Biologics LLC Corporate Summary
7.3.2 Cambryn Biologics LLC Business Overview
7.3.3 Cambryn Biologics LLC Coagulation Factor XI Major Product Offerings
7.3.4 Cambryn Biologics LLC Coagulation Factor XI Revenue in Global Market (2017-2022)
7.3.5 Cambryn Biologics LLC Key News
7.4 eXithera Pharmaceuticals, Inc
7.4.1 eXithera Pharmaceuticals, Inc Corporate Summary
7.4.2 eXithera Pharmaceuticals, Inc Business Overview
7.4.3 eXithera Pharmaceuticals, Inc Coagulation Factor XI Major Product Offerings
7.4.4 eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue in Global Market (2017-2022)
7.4.5 eXithera Pharmaceuticals, Inc Key News
7.5 Ionis Pharmaceuticals, Inc.
7.5.1 Ionis Pharmaceuticals, Inc. Corporate Summary
7.5.2 Ionis Pharmaceuticals, Inc. Business Overview
7.5.3 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Major Product Offerings
7.5.4 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue in Global Market (2017-2022)
7.5.5 Ionis Pharmaceuticals, Inc. Key News
7.6 LegoChem Biosciences, Inc
7.6.1 LegoChem Biosciences, Inc Corporate Summary
7.6.2 LegoChem Biosciences, Inc Business Overview
7.6.3 LegoChem Biosciences, Inc Coagulation Factor XI Major Product Offerings
7.6.4 LegoChem Biosciences, Inc Coagulation Factor XI Revenue in Global Market (2017-2022)
7.6.5 LegoChem Biosciences, Inc Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Coagulation Factor XI Market Opportunities & Trends in Global Market
Table 2. Coagulation Factor XI Market Drivers in Global Market
Table 3. Coagulation Factor XI Market Restraints in Global Market
Table 4. Key Players of Coagulation Factor XI in Global Market
Table 5. Top Coagulation Factor XI Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Coagulation Factor XI Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Coagulation Factor XI Revenue Share by Companies, 2017-2022
Table 8. Global Companies Coagulation Factor XI Product Type
Table 9. List of Global Tier 1 Coagulation Factor XI Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Coagulation Factor XI Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Coagulation Factor XI Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Coagulation Factor XI Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Coagulation Factor XI Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Coagulation Factor XI Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Coagulation Factor XI Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Coagulation Factor XI Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Coagulation Factor XI Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Coagulation Factor XI Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Coagulation Factor XI Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Coagulation Factor XI Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Coagulation Factor XI Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Coagulation Factor XI Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Coagulation Factor XI Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Coagulation Factor XI Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Coagulation Factor XI Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Coagulation Factor XI Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Coagulation Factor XI Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Coagulation Factor XI Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Coagulation Factor XI Revenue, (US$, Mn), 2023-2028
Table 30. Bayer AG Corporate Summary
Table 31. Bayer AG Coagulation Factor XI Product Offerings
Table 32. Bayer AG Coagulation Factor XI Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Company Corporate Summary
Table 34. Bristol-Myers Squibb Company Coagulation Factor XI Product Offerings
Table 35. Bristol-Myers Squibb Company Coagulation Factor XI Revenue (US$, Mn), (2017-2022)
Table 36. Cambryn Biologics LLC Corporate Summary
Table 37. Cambryn Biologics LLC Coagulation Factor XI Product Offerings
Table 38. Cambryn Biologics LLC Coagulation Factor XI Revenue (US$, Mn), (2017-2022)
Table 39. eXithera Pharmaceuticals, Inc Corporate Summary
Table 40. eXithera Pharmaceuticals, Inc Coagulation Factor XI Product Offerings
Table 41. eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue (US$, Mn), (2017-2022)
Table 42. Ionis Pharmaceuticals, Inc. Corporate Summary
Table 43. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product Offerings
Table 44. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue (US$, Mn), (2017-2022)
Table 45. LegoChem Biosciences, Inc Corporate Summary
Table 46. LegoChem Biosciences, Inc Coagulation Factor XI Product Offerings
Table 47. LegoChem Biosciences, Inc Coagulation Factor XI Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Coagulation Factor XI Segment by Type in 2021
Figure 2. Coagulation Factor XI Segment by Application in 2021
Figure 3. Global Coagulation Factor XI Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Coagulation Factor XI Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Coagulation Factor XI Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Coagulation Factor XI Revenue in 2021
Figure 8. By Type - Global Coagulation Factor XI Revenue Market Share, 2017-2028
Figure 9. By Application - Global Coagulation Factor XI Revenue Market Share, 2017-2028
Figure 10. By Region - Global Coagulation Factor XI Revenue Market Share, 2017-2028
Figure 11. By Country - North America Coagulation Factor XI Revenue Market Share, 2017-2028
Figure 12. US Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Coagulation Factor XI Revenue Market Share, 2017-2028
Figure 16. Germany Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 17. France Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Coagulation Factor XI Revenue Market Share, 2017-2028
Figure 24. China Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 28. India Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Coagulation Factor XI Revenue Market Share, 2017-2028
Figure 30. Brazil Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Coagulation Factor XI Revenue Market Share, 2017-2028
Figure 33. Turkey Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Coagulation Factor XI Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer AG Coagulation Factor XI Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Company Coagulation Factor XI Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cambryn Biologics LLC Coagulation Factor XI Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. LegoChem Biosciences, Inc Coagulation Factor XI Revenue Year Over Year Growth (US$, Mn) & (2017-2022)